Jubilant Therapeutics
Jubilant and The Wistar Insitute collaborate on potential COVID-19 treatment
January 18, 2021Sales and Marketing Jubilant Therapeutics
Jubilant Therapeutics, a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases, has …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
